Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGP-437 in cataract surgery patients
NCT02571556Phase 2Completed
- Sponsor
- Kiora Pharmaceuticals
- Start
- Nov 2015
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dexamethasone phosphate iontophoretic ophthalmic solution in post-operative inflammation and postoperative pain, sponsored by Kiora Pharmaceuticals. Primary endpoint: Proportion of subjects with an anterior chamber cell count of zero on Day 14. Started Nov 2015; status: completed.
02
Drugs
dexamethasone phosphate iontophoretic ophthalmic solution
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT02571556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02571556.